ID   KCNN4_RAT               Reviewed;         425 AA.
AC   Q9QYW1; Q9R198; Q9WVA5;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   16-NOV-2001, sequence version 2.
DT   02-OCT-2024, entry version 153.
DE   RecName: Full=Intermediate conductance calcium-activated potassium channel protein 4 {ECO:0000305};
DE            Short=SKCa 4;
DE            Short=SKCa4;
DE            Short=rSK4 {ECO:0000303|PubMed:10519135};
DE   AltName: Full=KCa3.1;
DE   AltName: Full=KCa4;
DE   AltName: Full=Smooth muscle intermediate-conductance KCa channel {ECO:0000303|PubMed:10532960};
DE            Short=SMIK {ECO:0000303|PubMed:10532960};
DE   AltName: Full=rIK1 {ECO:0000303|Ref.4};
GN   Name=Kcnn4 {ECO:0000312|RGD:621476}; Synonyms=Ik1, Sk4, Smik;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TRANSPORTER ACTIVITY.
RC   STRAIN=Wistar Kyoto; TISSUE=Aortic smooth muscle;
RX   PubMed=10532960; DOI=10.1161/01.res.85.9.e33;
RA   Neylon C., Lang R.J., Fu Y., Bobik A., Reinhart P.H.;
RT   "Molecular cloning and characterization of the intermediate-conductance
RT   Ca(2+)-activated K(+) channel in vascular smooth muscle: relationship
RT   between K(Ca) channel diversity and smooth muscle cell function.";
RL   Circ. Res. 85:E33-E43(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Colon;
RX   PubMed=10519135; DOI=10.1007/s004249900059;
RA   Warth R., Hamm K., Bleich M., Kunzelmann K., von Hahn T., Schreiber R.,
RA   Ullrich E., Mengel M., Trautmann N., Kindle P., Schwab A., Greger R.;
RT   "Molecular and functional characterization of the small Ca2+-regulated K+
RT   channel (rSK4) of colonic crypts.";
RL   Pflugers Arch. 438:437-444(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Fujiwara Y., Saito T., Sasamura R., Miura M.;
RT   "Rat intermediate conductance calcium-activated potassium channel.";
RL   Submitted (MAY-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley;
RA   Rajendran V.M., Sangan P., Joiner W.J., Binder H.J.;
RT   "cDNA cloning of an intermediate conductance Ca2+-activated K+ channel
RT   (rIK1) and its regulation by dietary K-depletion in rat distal colon.";
RL   Submitted (JUN-1999) to the EMBL/GenBank/DDBJ databases.
CC   -!- FUNCTION: Intermediate conductance calcium-activated potassium channel
CC       that mediates the voltage-independent transmembrane transfer of
CC       potassium across the cell membrane through a constitutive interaction
CC       with calmodulin which binds the intracellular calcium allowing its
CC       opening (PubMed:10532960). The current is characterized by a voltage-
CC       independent activation, an intracellular calcium concentration
CC       increase-dependent activation and a single-channel conductance of about
CC       25 picosiemens (PubMed:10532960). Also presents an inwardly rectifying
CC       current, thus reducing its already small outward conductance of
CC       potassium ions, which is particularly the case when the membrane
CC       potential displays positive values, above + 20 mV (By similarity).
CC       Controls calcium influx during vascular contractility by being
CC       responsible of membrane hyperpolarization induced by vasoactive factors
CC       in proliferative vascular smooth muscle cell types (PubMed:10532960).
CC       Following calcium influx, the consecutive activation of KCNN4 channel
CC       leads to a hyperpolarization of the cell membrane potential and hence
CC       an increase of the electrical driving force for further calcium influx
CC       promoting sustained calcium entry in response to stimulation with
CC       chemotactic peptides. Required for maximal calcium influx and
CC       proliferation during the reactivation of naive T-cells (By similarity).
CC       Plays a role in the late stages of EGF-induced macropinocytosis through
CC       activation by PI(3)P (By similarity). {ECO:0000250|UniProtKB:O15554,
CC       ECO:0000269|PubMed:10532960}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=K(+)(in) = K(+)(out); Xref=Rhea:RHEA:29463, ChEBI:CHEBI:29103;
CC         Evidence={ECO:0000269|PubMed:10532960};
CC   -!- SUBUNIT: Homodimer. Homotetramer. Heterotetramer of potassium channel
CC       proteins. Interacts with MTMR6; this interaction leads to selective
CC       dephosphorylation of PI(3)P in a lipid microdomain adjacent to KCNN4,
CC       resulting in a decrease of intermediate conductance calcium-activated
CC       potassium channel activity. Interacts (via the C-tail domain) with
CC       CALM1; the calmodulin binding is constitutive, does not require calcium
CC       and mediates calcium-dependent gating and four calmodulin molecules
CC       bind to one channel tetramer. {ECO:0000250|UniProtKB:O15554}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250|UniProtKB:O15554};
CC       Multi-pass membrane protein {ECO:0000255}. Cell projection, ruffle
CC       membrane {ECO:0000250|UniProtKB:O15554}. Note=Targeted to membrane
CC       ruffles after EGF stimulation. {ECO:0000250|UniProtKB:O15554}.
CC   -!- DOMAIN: Transmembrane helices S5 and S6 form the ion channel pore,
CC       which is surrounded bymembrane embedded helices S1 to S4. The S4-S5
CC       linker, which contains two distinct helices, undergoes conformational
CC       changes upon calmodulin binding to open the channel pore.
CC       {ECO:0000250|UniProtKB:O15554}.
CC   -!- PTM: Phosphorylation at His-356 by NDKB activates the intermediate
CC       conductance calcium-activated potassium channel activity, and
CC       conversely it's dephosphorylation by PHPT1 inhibits this activity.
CC       {ECO:0000250|UniProtKB:O15554}.
CC   -!- SIMILARITY: Belongs to the potassium channel KCNN family. KCa3.1/KCNN4
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF190458; AAF05602.1; -; mRNA.
DR   EMBL; AJ133438; CAB40141.2; -; mRNA.
DR   EMBL; AF149250; AAD38032.1; -; mRNA.
DR   EMBL; AF156554; AAD38205.1; -; mRNA.
DR   AlphaFoldDB; Q9QYW1; -.
DR   SMR; Q9QYW1; -.
DR   STRING; 10116.ENSRNOP00000026489; -.
DR   BindingDB; Q9QYW1; -.
DR   iPTMnet; Q9QYW1; -.
DR   PhosphoSitePlus; Q9QYW1; -.
DR   PaxDb; 10116-ENSRNOP00000026489; -.
DR   Ensembl; ENSRNOT00060057264; ENSRNOP00060047342; ENSRNOG00060033002.
DR   Ensembl; ENSRNOT00065057758; ENSRNOP00065047544; ENSRNOG00065033610.
DR   UCSC; RGD:621476; rat.
DR   AGR; RGD:621476; -.
DR   RGD; 621476; Kcnn4.
DR   eggNOG; KOG3684; Eukaryota.
DR   InParanoid; Q9QYW1; -.
DR   PhylomeDB; Q9QYW1; -.
DR   Reactome; R-RNO-1296052; Ca2+ activated K+ channels.
DR   PRO; PR:Q9QYW1; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0031982; C:vesicle; ISO:RGD.
DR   GO; GO:0015269; F:calcium-activated potassium channel activity; ISO:RGD.
DR   GO; GO:0005516; F:calmodulin binding; IBA:GO_Central.
DR   GO; GO:0022894; F:intermediate conductance calcium-activated potassium channel activity; IDA:RGD.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:RGD.
DR   GO; GO:0005267; F:potassium channel activity; ISO:RGD.
DR   GO; GO:0019903; F:protein phosphatase binding; ISO:RGD.
DR   GO; GO:0016286; F:small conductance calcium-activated potassium channel activity; IEA:InterPro.
DR   GO; GO:0006816; P:calcium ion transport; ISO:RGD.
DR   GO; GO:0003300; P:cardiac muscle hypertrophy; IMP:RGD.
DR   GO; GO:0006884; P:cell volume homeostasis; ISO:RGD.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:RGD.
DR   GO; GO:0051649; P:establishment of localization in cell; ISO:RGD.
DR   GO; GO:0097284; P:hepatocyte apoptotic process; IMP:RGD.
DR   GO; GO:0006820; P:monoatomic anion transport; IDA:RGD.
DR   GO; GO:0071674; P:mononuclear cell migration; IMP:RGD.
DR   GO; GO:0010614; P:negative regulation of cardiac muscle hypertrophy; IMP:RGD.
DR   GO; GO:0045794; P:negative regulation of cell volume; IMP:RGD.
DR   GO; GO:1904898; P:negative regulation of hepatic stellate cell proliferation; IMP:RGD.
DR   GO; GO:0045332; P:phospholipid translocation; ISO:RGD.
DR   GO; GO:0070318; P:positive regulation of G0 to G1 transition; IMP:RGD.
DR   GO; GO:1903980; P:positive regulation of microglial cell activation; IMP:RGD.
DR   GO; GO:1900745; P:positive regulation of p38MAPK cascade; IMP:RGD.
DR   GO; GO:0050714; P:positive regulation of protein secretion; ISO:RGD.
DR   GO; GO:0048661; P:positive regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0050862; P:positive regulation of T cell receptor signaling pathway; ISO:RGD.
DR   GO; GO:0097623; P:potassium ion export across plasma membrane; IDA:RGD.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:UniProtKB.
DR   GO; GO:0006813; P:potassium ion transport; IDA:RGD.
DR   GO; GO:0002002; P:regulation of angiotensin levels in blood; IMP:RGD.
DR   GO; GO:0071637; P:regulation of monocyte chemotactic protein-1 production; IMP:RGD.
DR   GO; GO:1900133; P:regulation of renin secretion into blood stream; IMP:RGD.
DR   GO; GO:0048660; P:regulation of smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0032680; P:regulation of tumor necrosis factor production; IMP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0032868; P:response to insulin; IEP:RGD.
DR   GO; GO:1904772; P:response to tetrachloromethane; IEP:RGD.
DR   GO; GO:0046541; P:saliva secretion; ISO:RGD.
DR   GO; GO:0030322; P:stabilization of membrane potential; ISO:RGD.
DR   GO; GO:1904738; P:vascular associated smooth muscle cell migration; IMP:RGD.
DR   GO; GO:1990874; P:vascular associated smooth muscle cell proliferation; IEP:RGD.
DR   Gene3D; 1.10.287.70; -; 2.
DR   InterPro; IPR004178; CaM-bd_dom.
DR   InterPro; IPR036122; CaM-bd_dom_sf.
DR   InterPro; IPR015449; K_chnl_Ca-activ_SK.
DR   InterPro; IPR013099; K_chnl_dom.
DR   PANTHER; PTHR10153:SF41; INTERMEDIATE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL PROTEIN 4; 1.
DR   PANTHER; PTHR10153; SMALL CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL; 1.
DR   Pfam; PF02888; CaMBD; 1.
DR   Pfam; PF07885; Ion_trans_2; 1.
DR   Pfam; PF03530; SK_channel; 1.
DR   SMART; SM01053; CaMBD; 1.
DR   SUPFAM; SSF81327; Small-conductance potassium channel; 1.
DR   SUPFAM; SSF81324; Voltage-gated potassium channels; 1.
PE   2: Evidence at transcript level;
KW   Calmodulin-binding; Cell membrane; Cell projection; Immunity; Ion channel;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Transmembrane;
KW   Transmembrane helix; Transport.
FT   CHAIN           1..425
FT                   /note="Intermediate conductance calcium-activated potassium
FT                   channel protein 4"
FT                   /id="PRO_0000155019"
FT   TRANSMEM        30..50
FT                   /note="Helical; Name=Segment S1"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        59..79
FT                   /note="Helical; Name=Segment S2"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        105..121
FT                   /note="Helical; Name=Segment S3"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        141..161
FT                   /note="Helical; Name=Segment S4"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        205..225
FT                   /note="Helical; Name=Segment S5"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        239..259
FT                   /note="Pore-forming; Name=Segment H5"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        263..283
FT                   /note="Helical; Name=Segment S6"
FT                   /evidence="ECO:0000255"
FT   REGION          284..345
FT                   /note="Calmodulin-binding"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         356
FT                   /note="Phosphohistidine"
FT                   /evidence="ECO:0000250|UniProtKB:O15554"
FT   CONFLICT        213
FT                   /note="L -> F (in Ref. 2; CAB40141)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        280
FT                   /note="V -> L (in Ref. 4; AAD38205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        395
FT                   /note="D -> H (in Ref. 4; AAD38205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="G -> R (in Ref. 4; AAD38205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        410
FT                   /note="T -> S (in Ref. 4; AAD38205)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        416
FT                   /note="Missing (in Ref. 4; AAD38205)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   425 AA;  47767 MW;  E861DB088D20D8FC CRC64;
     MGGELVTGLG ALRRRKRLLE QEKRVAGWAL VLAGTGIGLM VLHAEMLWFL GCKWVLYLLL
     VKCLITLSTA FLLCLIVVFH AKEVQLFMTD NGLRDWRVAL TRRQVAQILL ELLVCGVHPV
     PLRSPHCTLA GEATDSQAWP GFLGEGEALL SLAMLLRLYL VPRAVLLRSG VLLNASYRSI
     GALNQVRFRH WFVAKLYMNT HPGRLLLGLT LGLWLTTAWV LSVAERQAVN ATGHLTDTLW
     LIPITFLTIG YGDVVPGTLW GKIVCLCTGV MGVCCTALLV AVVARKLEFN KAEKHVHNFM
     MDIHYAKEMK ESAARLLQEA WMYYKHTRRK DSRAARRHQR KMLAAIHTFR QVRLKHRKLR
     EQVNSMVDIS KMHMILCDLQ LGLSASHLAL EKRIDGLAGK LDALTELLST ALQQQQPPEP
     IQEAT
//
